Navigation Links
Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences
Date:12/1/2011

al models demonstrated that resistance to aromatase inhibitors occurs through up-regulation of growth factor signaling pathways and down-regulation of estrogen receptor-alpha (ERa). Entinostat effectively down-regulates growth factor signaling in breast cancer cells where these pathways are active. Entinostat also up-regulates the expression of ER in breast cancer cells which have negligible or undetectable levels of ER. The ability to target multiple mechanisms of resistance establishes entinostat as a promising candidate for preventing and overcoming aromatase inhibitor resistance through epigenetic modulation. In pre-clinical testing entinostat induced tumor regression when combined with an aromatase inhibitor after the development of hormone resistance.

Additional phase 2 studies with entinostat have demonstrated promising results in combination with the EGFR-TKI erlotinib (ENCORE 401) and DNA methyltransfer inhibitor azacitidine in non-small cell lung cancer).  Results from the ENCORE clinical program have provided the basis for moving entinostat in pivotal, phase 3 testing across a platform of breast and lung cancer indications.

About Syndax
Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, late-stage, oncology-focused pharmaceutical company. The company is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens. Syndax has worldwide rights to develop and commercialize entinostat which has shown promise in randomized clinical trials in solid tumors. Syndax is backed by top-tier Venture Capital firms: Domain Associates, MPM Capital, Avalon, Pappas and Forward Ventures. Formed in 2005, Syndax's intelle
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
2. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
4. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
5. Biogen-Idecs BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
6. Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
7. Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
8. DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Calipers LabChip® Dx Platform
9. Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
10. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
11. Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Published in the Journal of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...
(Date:5/17/2013)... 2013 Oramed Pharmaceuticals Inc. (NASDAQCM: ... delivery systems, announced today that the United States Food ... New Drug application(IND) for ORMD-0801, its oral insulin capsule. ... FDA clearance to proceed," stated Nadav Kidron ... a major milestone for Oramed and we look forward ...
(Date:5/16/2013)... and MECHELEN, Belgium , May ... AbbVie (NYSE: ABBV ) announced today an ... Crohn,s disease.  Galapagos will fund and complete a Phase ... facilitate rapid progression into Phase 3.  Upon successful completion ... pay Galapagos $50 million.  The terms of the collaboration ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... , WESTBROOK, Maine, Jan. 11 IDEXX ... it placed in excess of 2,000 Catalyst Dx® chemistry ... 2,800. Catalyst Dx, introduced in the first quarter of ... to the IDEXX VetLab® integrated suite of analyzers and ...
... , , LAGUNA BEACH, California, January ... irrigated cardiac,ablation systems, announced today that it has completed a ... NBGI Ventures, a venture,capital firm specialized in medical technology investments, ... ACT was founded in 2007 to develop a ...
Cached Medicine Technology:IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers 2Advanced Cardiac Therapeutics Completes $5 Million Financing 2Advanced Cardiac Therapeutics Completes $5 Million Financing 3
(Date:5/18/2013)... New York, New York (PRWEB) May 18, 2013 ... Inc.’s Gynecare pelvic mesh products continue to move forward ... County Superior Court, Bernstein Liebhard LLP reports. According to ... Management Conference in the Ethicon pelvic mesh litigation will ... indicate that 2,755 complaints have been filed in the ...
(Date:5/18/2013)... FL (PRWEB) May 18, 2013 TheBeautyPlace.com ... Nioxin. Pattern hair loss is not a result of ... According to Men’s Fitness Magazine, 70% of men suffer ... Professional Strength is renowned for hair transplant surgery, ... fights male pattern baldness known as Bosley Professional Strength. ...
(Date:5/18/2013)... Simple changes in a person’s every day routine, ... water can lead to substantial health benefits, the proven ... Diet Doc understands that overcoming significant weight ... difficult and often requires the use of prescription strength ... get over initial weight loss hurdles. In addition to ...
(Date:5/18/2013)... 2013 The Ayurvedic practitioner program will ... in the West. Program is available in Mexico via ... a healing modality practiced for over 5,000 years. In ... that health begins when an individual lives in harmony ... individual needs. Ayurveda aims to heal an individual in ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental laser ... of the root causes of sleep apnea to provide and ... Sleep Month, Dr. Tracey points out estimates revealing that 40 ... sleep apnea is one of the most common of all. ... breathing at different times while sleeping. When this happens, the ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3
... ... force to promote interest of oil rig crews and other maritime industry employees. , ... Houston, Texas (PRWEB) April 22, 2010 ... illustrates the hazardous and sometimes deadly work conditions that maritime workers face on a daily ...
... new options to treat type 1 diabetes, , WEDNESDAY, April ... kind, a wounded soldier whose damaged pancreas had to be ... transplanted back into him, sparing him from a life with ... In November 2009, 21-year-old Senior Airman Tre Porfirio was serving ...
... have varying opinions on how much control a person has ... of Iowa researchers suggests that when doctor and patient attitudes ... of taking their medications. Published online and in the ... the study is part of a growing body of ...
... can cause pneumonia and meningitis, researchers point out , WEDNESDAY, ... of the PCV7 vaccine to battle bacteria that causes ... notable changes in strains that cause these illnesses, researchers report. ... covered by the vaccine, the team aid. , Immunizations with ...
... young viewing audience* and their ideas about gender and violence. ... . Film theorists believe that the action character Lt. ... 1979, paved the way for a new type of female ... see female action characters take part in hand-to-hand combat, wield ...
... likely to be screened, study finds , WEDNESDAY, April 21 ... are being screened for skin cancer, a particular problem among ... common cancer screenings, a new study has found. , Researchers ... and older, who took part in the 2005 National Health ...
Cached Medicine News:Health News:Explosion on Gulf Coast Oil Rig Underscores Daily Dangers for Maritime Workers, Say Houston Maritime Injury Lawyers Arnold & Itkin LLP 2Health News:Wounded Soldier Spared Diabetes With Emergency Transplant 2Health News:Wounded Soldier Spared Diabetes With Emergency Transplant 3Health News:Wounded Soldier Spared Diabetes With Emergency Transplant 4Health News:Patient-physician compatibility increases odds of following doctor's orders 2Health News:Patient-physician compatibility increases odds of following doctor's orders 3Health News:Vaccine Now Misses Many Pneumococcal Infections in Kids 2Health News:Tough girl or sidechick? 2Health News:Few Over 50 Get Skin Cancer Screenings 2
... tool for the Humphrey Field Analyzer, ... and shows less inter-test variability than ... degree of reproducibility as Full Threshold ... correlate with the earlier glaucoma damage ...
... is the smartest, toughest and most technologically ... on-board artificial intelligence algorithm, DiogenesTM, the Decipher ... while on the patient. The Decipher was ... the rigorous tests required to monitor the ...
... is a top quality Carl Zeiss Meditec ... vision defects even safer, more patient-friendly and ... work platform are oriented towards increasing efficiency, ... recovery of vision. Key factors here are ...
The Vivid e delivers everything you need in a compact echo system, like complete cardiovascular functionality, a comprehensive cardiac measurement and analysis package, and full shared service capabi...
Medicine Products: